论文部分内容阅读
目的:研究静脉注射参芎葡萄糖注射液对慢性阻塞性肺疾病急性加重期(AECOPD)合并心血管病的疗效。方法:将36例慢性阻塞性肺疾病(COPD)合并心血管病住院患者随机分为治疗组与对照组,两组均常规按COPD指南给予吸氧、抗感染、袪痰、支气管扩张剂、硝酸甘油、他汀类调脂药、拜阿司匹林等治疗,对照组在同等治疗下给予参芎葡萄糖注射液静脉滴注。结果:治疗组咳嗽、咳痰等临床症状以及动脉血气分析、心功能改善情况优于对照组。结论:参芎葡萄糖注射液对慢性阻塞性肺疾病急性加重期合并的心血管病有效。
Objective: To study the effect of intravenous injection of Shenxiong and glucose injection on patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and cardiovascular diseases. Methods: Thirty-six patients with chronic obstructive pulmonary disease (COPD) and cardiovascular disease were randomly divided into treatment group and control group. Both groups were routinely given COPD guidelines for oxygen inhalation, anti-infective, sputum, bronchodilators, nitric acid Glycerin, statin lipid-lowering drugs, thanks to aspirin and other treatment, the control group given the same treatment of intravenous infusion of decoction of glucose injection. Results: The treatment group cough, sputum and other clinical symptoms as well as arterial blood gas analysis, cardiac function improvement is better than the control group. Conclusion: Shenxiong glucose injection is effective in the treatment of cardiovascular diseases complicated by acute exacerbation of chronic obstructive pulmonary disease.